Celtaxsys, Inc. Email Format
PharmaceuticalsGeorgia, United States11-50 Employees
Celtaxsys, Inc. is a small to mid-sized pharmaceutical development company based in Atlanta, Georgia, focused on advancing anti-inflammatory therapies for rare, orphan diseases. It operates at the clinical stage, pursuing treatments that address dysregulated immune responses. Its lead program, acebilustat, is an oral medication taken once daily and designed to modulate components of an overactive inflammatory reaction with the aim of preserving lung function in cystic fibrosis. Focused on patients with cystic fibrosis and other rare diseases, Celtaxsys aims to complement existing therapies by guiding the immune system toward a more balanced state. It is a small to mid-sized company located in Atlanta, operating within the pharmaceutical manufacturing sector with an emphasis on inflammation.